West Pharmaceutical Services (WST) Gains from Sales and Divestitures (2009 - 2011)

West Pharmaceutical Services has disclosed Gains from Sales and Divestitures across 3 years of filings, most recently posting -$3963.0 for Q4 2011.

• Gains from Sales and Divestitures for Q4 2011 came in at -$3963.0, up 92.13% year-over-year; the trailing twelve-month figure through Dec 2011 was -$3963.0 (up 92.13% YoY), and the FY2011 annual result was -$3963.0, up 92.13% from the prior year.
• Gains from Sales and Divestitures came in at -$3963.0 for Q4 2011 at West Pharmaceutical Services, up from -$50337.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of -$3963.0 in Q4 2011 to a low of -$50337.0 in Q4 2010.
• The 3-year median for Gains from Sales and Divestitures is -$5409.0 (2009), against an average of -$19903.0.
• Across the five-year window, Gains from Sales and Divestitures tumbled 830.62% in 2010 and soared 92.13% in 2011, its largest moves.
• West Pharmaceutical Services' Gains from Sales and Divestitures stood at -$5409.0 in 2009, then sank by 830.62% to -$50337.0 in 2010, then jumped by 92.13% to -$3963.0 in 2011.
• The last three Gains from Sales and Divestitures figures came in at -$3963.0 (Q4 2011), -$50337.0 (Q4 2010), and -$5409.0 (Q4 2009), per Business Quant data.